PEPFAR Commits to Distributing Breakthrough HIV Drug Lenacapavir Demonstrating American Excellence in Science and American Leadership in HIV Prevention
Fact Sheet September 4, 2025 The U.S. government is making a pre-market commitment to purchase the drug lenacapavir from Gilead Sciences, an American Company. Lenacapavir is a new, extremely effective HIV prevention injection that only has to be taken twice a year. The President’s Emergency Plan for AIDS Relief (PEPFAR) will distribute lenacapavir in 8-12 …
